SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-012473
Filing Date
2019-07-11
Accepted
2019-07-11 06:30:34
Documents
4
Period of Report
2019-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k070919_xynomicpharma.htm 8-K 27462
2 FORM OF SECURITIES PURCHASE AGREEMENT BY AND AMONG THE COMPANY AND THE PURCHASER f8k070919ex10-1_xynomic.htm EX-10.1 115227
3 FORM OF WARRANTS f8k070919ex10-2_xynomic.htm EX-10.2 106156
4 GRAPHIC ex10-2_001.jpg GRAPHIC 3463
  Complete submission text file 0001213900-19-012473.txt   255189
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38120 | Film No.: 19950314
SIC: 2834 Pharmaceutical Preparations